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TRENDS IN PHARMACEUTICAL SPENDING GROWTH IN THE
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Roberts WM, Rindress D
BioMedCom Consultants, inc, Montréal, QC, Canada
OBJECTIVES: Increasing drug utilization, increasing average
drug cost, or both may be responsible for pharmaceutical spend-
ing growth in the US. Recent trends in outpatient drug utiliza-
tion were examined to assess the relative contribution of both
factors. METHODS: Five-year trends in expenditures and pre-
scribing rates for outpatient drugs were estimated by analyzing
the most recently available nationally representative data from
the Medical Expenditure Panel Survey (MEPS), National Ambu-
latory Medical Care Survey (NAMCS) and National Hospital
Ambulatory Medical Care Survey (NHAMCS). RESULTS:
MEPS data indicate that from 1998 to 2002 outpatient pre-
scription drug expenditures (excluding inpatient prescriptions,
over-the-counter medicines and samples) nearly doubled from
$78 billion to $151 billion. Total number of prescription drug
purchases increased by 37%, while average cost per prescription
increased by 41%. Over the same period, NAMCS and
NHAMCS data reveal that physician ofﬁce, hospital outpatient
department and emergency department visits accounted for
81%, 8%, and 11%, respectively, of medications given at out-
patient visits (prescribed or provided). For visits at which med-
ications were given, number of visits increased by 6.9%, 12.6%
and 16.6%, and number of medications per visit increased by
6.6%, 8.5%, and 13.5% for physician ofﬁce, outpatient depart-
ment, and emergency department visits, respectively. However,
the proportion of physician ofﬁce and outpatient department
visits at which drugs were given remained relatively constant at
approximately 65%. The proportion of emergency department
visits at which drugs were given increased from 71.3% to 75.8%.
CONCLUSION: Total drug utilization and average drug cost
both increased to a comparable degree between 1998 and 2002.
Although the total number of visits and the average number of
drugs given per visit increased, the proportion of health care
visits at which outpatients received drugs or prescriptions was
relatively stable. Increased utilization was greater for emergency
department visits than for physician ofﬁce or hospital outpatient
department visits.
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IMPACT OF HEALTH INSURANCE ON HEALTH-RELATED
QUALITY OF LIFE
Bharmal M,Thomas III J
Purdue University, West Lafayette, IN, USA
OBJECTIVES: Relationships between health insurance status
and health-related quality of life (HRQOL) were investigated.
METHODS: The 2000 Medical Expenditure Panel Survey data
were analyzed to examine relationships between health insurance
status and health-related quality of life. HRQOL was measured
using the SF-12 Physical Component Summary (PCS) and SF-12
Mental Component Summary (MCS). The sample included
adults aged 25 to 64 years who did not have Medicaid or
Medicare coverage. Respondents who were insured for only part
of the year were excluded from the analysis. Survey weighted
multiple regression models using SAS version 8.2 were used for
the analysis. The analysis controlled for sociodemographic vari-
ables, attitudinal variables and medical conditions. The analysis
also investigated and controlled for the possible endogeneity of
the health insurance status variable in the models. RESULTS: Of
the 8141 adults in the sample that met inclusion criteria, 1449
(17.79%) were without health insurance for the entire year. Tests
were positive for endogeneity of the health insurance status in
PCS model but not in the MCS model. After adjusting for covari-
ates that included age, gender, race, education, income, attitude
towards the value of health insurance and health care, and pres-
ence or absence of each of nine reported medical conditions, indi-
viduals without health insurance had signiﬁcantly lower PCS
scores than those with health insurance. Individuals with family
income above 200% of federal poverty level had a higher detri-
mental effect of absence of health insurance on PCS compared
to individuals with family income below 200% of federal
poverty level (Beta = -10.85 versus Beta = -8.21). The adjusted
adverse effect of no health insurance also was signiﬁcant in the
MCS model (Beta = -1.43; SE = 0.49). CONCLUSIONS: The
detrimental effect of lack of health insurance on HRQOL equals
or exceeds the detrimental effect of many serious medical con-
ditions on HRQOL.
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OBJECTIVES: The objectives of this work are oriented in the
ﬁrst place to discuss the modalities of the ﬁnancing of medicines,
in special to study the characteristics of the access forms and
ﬁnancing to medicines according to the level of the income of
the household in Mexico. In the industrialized countries the
forms of ﬁnancing of medicines, like the ﬁnancing to the services
of health is made by means of some scheme of copayment or
subsidy the vulnerable groups. But in the non industrialized
countries the main form of ﬁnancing of medicines comes 
from the out-of-pocket household which is very inequitative.
METHODS: For this study the registries of the surveys of house-
holds income by 2002 of Mexico to study the medicine expen-
diture by deciles of income. With this information the coefﬁcients
of Gini and the curve of Lorenz are considered. Additionally it
is used the public and private information on the price and the
cost in medicines. RESULTS: The access to medicines in Mexico
is not related to the necessities of health but to the availability
of income of the households, because 85 % of the medicines are
acquired by means of the out-of-pocket money of households,
because the social security provides free of charge medicines only
15 % of them. The income survey cost of the homes sample that
39 % of the medicine consumption in the private market both
make last deciles of greater income; also one is that the con-
sumption of the decil of greater income is four times superior to
the one of the population with smaller income. CONCLU-
SIONS: The access to medicines in Mexico are not related to
health needs but to household income. Also medicine prices 
constitutes an effective barrier to medicine acces to a suitable
therapy.
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OBJECTIVES: To investigate the determinants of expenditures
on pharmaceuticals and other medical non-durables in OECD
(Organization for Economic Cooperation and Development)
countries. METHODS: This is a cross-sectional study using year
2000 data for twenty-seven OECD countries. The dependent
